Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites.
cancer center
cancer prevention
low-dose CT scans
lung cancer
lung cancer screening
national guidelines for screening and prevention
pharmaceutical aids to smoking cessation
smoking cessation
tobacco control
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
11 Jun 2020
11 Jun 2020
Historique:
received:
18
04
2020
revised:
30
05
2020
accepted:
09
06
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
Lung cancer is one of the deadliest and yet largely preventable neoplasms. Smoking cessation and lung cancer screening are effective yet underutilized lung cancer interventions. City of Hope Medical Center, a National Cancer Institute (NCI)- designated comprehensive cancer center, has 27 community cancer centers and has prioritized tobacco control and lung cancer screening throughout its network. Despite challenges, we are implementing and monitoring the City of Hope Tobacco Control Initiative including 1) a Planning and Implementation Committee; 2) integration of IT, e.g., medical records and clinician notification/prompts to facilitate screening, cessation referral, and digital health, e.g., telehealth and social media; 3) clinician training and endorsing national guidelines; 4) providing clinical champions at all sites for site leadership; 5) Coverage and Payment reform and aids to facilitate patient access and reduce cost barriers; 6) increasing tobacco exposure screening for all patients; 7) smoking cessation intervention and evaluation-patient-centered recommendations for smoking cessation for all current and recent quitters along with including QuitLine referral for current smokers and smoking care-givers; and 8) establishing a Tobacco Registry for advancing science and discoveries including team science for basic, translation and clinical studies. These strategies are intended to inform screening, prevention and treatment research and patient-centered care.
Identifiants
pubmed: 32545244
pii: jcm9061820
doi: 10.3390/jcm9061820
pmc: PMC7356827
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : K12 CA001727
Pays : United States
Organisme : NIH HHS
ID : P30 CA033572
Pays : United States
Références
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
J Natl Compr Canc Netw. 2016 Nov;14(11):1430-1468
pubmed: 27799513
Ann Intern Med. 2015 Apr 7;162(7):485-91
pubmed: 25664444
Lung Cancer. 2009 Sep;65(3):274-83
pubmed: 19128856
Am J Ind Med. 2010 May;53(5):476-85
pubmed: 20187007
JAMA. 2005 Sep 28;294(12):1505-10
pubmed: 16189363
Int J Cancer. 1997 Jan 6;70(1):57-62
pubmed: 8985091
MMWR Morb Mortal Wkly Rep. 2020 Feb 28;69(8):201-206
pubmed: 32106215
Clin Cancer Res. 2009 Sep 15;15(18):5626-45
pubmed: 19755391
JAMA Oncol. 2017 Sep 1;3(9):1278-1281
pubmed: 28152136
J Thorac Oncol. 2016 Nov;11(11):1856-1862
pubmed: 27346412
N Engl J Med. 2018 Jan 18;378(3):214-216
pubmed: 29342387
JAMA Netw Open. 2019 Nov 1;2(11):e1915619
pubmed: 31730186
Ann Oncol. 2013 Oct;24(10):2606-11
pubmed: 23956193
Transl Lung Cancer Res. 2018 Jun;7(3):234-242
pubmed: 30050762